Qube Research & Technologies (QRT)
CASI

Qube Research & Technologies (QRT)’s CASI Pharmaceuticals CASI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$550 – 3379
2024
Q2 		$550 Buy
+100
New +$311 ﹤0.01% 3307
2023
Q4 		– Sell
-328
Closed -$840 – 4367
2023
Q3 		$840 Buy
+328
New +$777 ﹤0.01% 3643
2021
Q4 		– Sell
-1,051
Closed -$13K – 2561
2021
Q3 		$13K Buy
+1,051
New +$14.2K ﹤0.01% 2014

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return